|
Match
|
Document |
Document Title |
|
|
6867178 |
Calorically dense nutritional composition
An enteral composition and method for providing nutrition to metabolically stressed patients. The enteral composition has an energy density of about 1.4 to 1.8 kcal/ml. The enteral composition...
|
|
|
6867230 |
Hygromycin A derivatives
This invention relates to compounds of the formula
and to pharmaceutically acceptable salts, prodrugs and solvates thereof, wherein R 1 , R 2 , R 3 and R 10 are as defined herein. The...
|
|
|
6858209 |
Means for detecting bacteria of the taylorella equigenitalis species and their biological applications
Means for detection of bacteria of the genus Taylorella and biological applications thereof are described. In particular, the detection of T. equigenitalis and the treatment or prevention of...
|
|
|
6855727 |
Muscular fatigue-controlling composition and method for providing muscular fatigue-controlling effect
An antifatigue composition for reducing muscular fatigue or the like during or after exercise, which includes an imidazole compound obtained from extracts of fishes, shelifishes, fowl, flesh or the...
|
|
|
6855734 |
Glycine betaine and its use
Pharmaceutical uses of glycine betaine, such as for the treatment of thromboses not induced by hyperhomocystenemia or homocystinuria, of blood disorders, such as blood coagulation, thrombi formation.
|
|
|
6852701 |
Anticonvulsant derivatives useful for preventing the development of Type II diabetes mellitus and Syndrome X
Anticonvulsant derivatives useful for preventing the development of Type II diabetes mellitus and Syndrome X are disclosed.
|
|
|
6846494 |
Nutritional composition for the treatment of pressure ulcers
A nutritional booster composition suitable for the treatment of pressure ulcers, comprising proteins, carbohydrates and fats and, in a daily unit dose: 3-15 g of arginine or equivalents thereof,...
|
|
|
6841172 |
Method for iron delivery to a patient by transfer from dialysate
The invention relates to methods and compositions for delivering iron to an iron-deficient patient, more particularly, to methods whereby an iron complex comprising divalent or trivalent ionic iron...
|
|
|
6841536 |
Prodrugs and conjugates of thiol- and selenol-containing compounds and methods of use thereof
Disclosed is a prodrug of the formula:
where A is a sulfur or a selenium, and R is derived from a mono- di- or oligo- saccharide.
Also disclosed is a prodrug of the formula:
where A is...
|
|
|
6835397 |
Controlled release encapsulated bioactive substances
The present invention is an encapsulated yeast composite comprising a core comprising yeast and a coating containing an emulsifiable lipid. The yeast includes Saccharomyces cerevisiae . The...
|
|
|
6835715 |
Mammalian dihydroouabain-like factor and therapeutic compositions
A novel mammalian dihydroouabain-like factor is disclosed which substantially fails to cross-react with mammalian ouabain-like factor (OLF) for binding to anti-OLF antibody, but cross-reacts with...
|
|
|
6833360 |
Process for preparing pseudoephedrine tannate
The invention pertains to a method for preparing pseudoephedrine tannate by reacting pseudoephedrine free base at a temperature of about 70 to about 110° C. with tannic acid neat or as an aqueous...
|
|
|
6833362 |
Method and composition for the accelerated in vivo removal of ethanol
A composition for accelerating the disposal of ethanol from bodily fluid. Certain additives can accelerate the metabolic oxidation of ethanol, and others in addition act as catalysts or...
|
|
|
6830745 |
Compositions for treating biofilm
A two component composition comprises an anchor enzyme complex to degrade biofilm structures and a second anchor enzyme component having the capability to act directly upon the bacteria for a...
|
|
|
6825178 |
Methods and products for treating pseudomonas infection
Methods and products for upregulating cystic fibrosis transmembrane conductance regulators are provided, including methods and products for the treatment of P. aeruginosa infection. The products...
|
|
|
6815424 |
Intranasal administration of polypeptides in powdered form
Pharmaceutical compositions of biologically active polypeptides in powder form suitable for nasal administration, comprising a therapeutically effective amount of a biologically active polypeptide...
|
|
|
6815212 |
Methods and compositions for enhancing sensitivity in the analysis of biological-based assays
Methods are provided for detecting the binding of a first member to a second member of a ligand pair, comprising the steps of (a) combining a set of first tagged members with a biological sample...
|
|
|
6809120 |
Composition containing propargylamine for enhancing cancer therapy
Antineoplastic drug modulators are described. The specific modulators referred to are propargylamines which can enhance the cytotoxic effects of antineoplastic drugs on cancer cells while...
|
|
|
6806257 |
Flavones as inducible nitric oxide synthase inhibitors, cyclooxygenase-2 inhibitors and potassium channel activators
The present invention is directed to a method for inhibiting expression of either iNOS or COX-2, or both in mammals using flavone compounds, and pharmaceutically acceptable salts thereof. The...
|
|
|
6790837 |
Ribavirin syrup formulations
A liquid formulation comprising ribavirin having a longer shelf life and improved taste is disclosed.
|
|
|
6784209 |
Food supplement for increasing lean mass and strength
Food supplement compositions and their methods of use in increasing lean mass and/or muscle size and/or strength in individuals, particularly, athletes is described. The food supplements described...
|
|
|
6783757 |
Composition and method for increasing exorphin catabolism to treat autism
A composition for use in treating autism spectrum disorders. The composition preferably includes a genomeceutical type compound that increases the user's expression of DPPIV or like substances. The...
|
|
|
6780849 |
Lipid-based nitric oxide donors
Novel nitric-oxide releasing lipid molecules are provided which comprise a lipid molecule selected from (a) phosphoglycerides, (b) lipids having a sphingosine base as a backbone, (c)...
|
|
|
6777391 |
Composition for an infant formula having a low threonine content
A composition for an infant formula which comprises a low threonine content; a method of producing the composition; use of the composition in the manufacture of a medicament or nutritional product...
|
|
|
6777397 |
Mixtures of fructose and lactose as a low-calorie bulk sweetener with reduced glycemic index
Mixtures of fructose and lactose are useful for reducing caloric intake and glycemic index for individuals who are overweight, glucose-impaired, diabetic, or who just consume too large a fraction...
|
|
|
6777004 |
Composition containing novel compound corniculatonin having antifungi properties and a process for preparing the same
The invention relates to a novel compound oleanane triterpenoid oligoglycoside of formula 1 of the accompanying drawing (trivially called corniculatonin), the invention also relates to a process...
|
|
|
6773729 |
Combination of Ginseng and Ginkgo to improve cognitive skills
A dietary supplement consisting essentially of a combination of Ginseng and Ginkgo to improve the speed of memory and memory quality in normal, healthy subjects and to prevent deterioration of the...
|
|
|
6774111 |
Carbohydrate system and a method for providing nutrition to a diabetic
The two carbohydrate mixture of this invention utilizes a source of fructose in combination with at least one readily digestible glucose polymer source. The addition of the fructose significantly...
|
|
|
6774180 |
Synthesis of high molecular weight non-peptidic polymer derivatives
High molecular weight derivatives of activated poly(ethylene glycol) and the like polymers are prepared in high purity by conjugating a large PEG molecule to a small PEG molecule. Most of the...
|
|
|
6774112 |
Amino acid complexes of C-aryl glucosides for treatment of diabetes and method
Crystalline complexes are obtained from a 1:1 or 2:1 mixtures of either the (D) or (L) enantiomer of natural amino acids and compounds of formula wherein R 1 , R 2 and R 2a are independently...
|
|
|
6770630 |
Naringenin derivatives and use thereof
A naringenin derivative of the general formula I: where R 1 and R 2 each represents either a hydrogen atom or β-D-glucosyl group, and but both R 1 and R 2 are not identical.
|
|
|
6767898 |
Methods for using specific saccharides for treating alzheimer's disease and other amyloidoses
A pharmaceutical agent for treating an amyloid disease in a patient, wherein the pharmaceutical agent comprises a glucose monosaccharide containing at least one anionic group, or a pharmaceutically...
|
|
|
6761912 |
Composition for increasing bone density
A composition and a method for administering an improved supplement to prevent bone density loss. The composition combines a calcium compound with inulin, and optionally magnesium, Vitamin D 3 ,...
|
|
|
6753319 |
D-mannose contraceptives
The present invention concerns the use of D-Mannose to prevent or inhibit uniting of sperm and egg in the conception process. The administration of D-Mannose to a female such that the environment...
|
|
|
6750209 |
Advanced glycation end-product intermediaries and post-amadori inhibition
The instant invention provides compositions and methods for modeling post-Amadori AGE formation and the identification and characterization of effective inhibitors of post-Amadori AGE formation,...
|
|
|
6749870 |
Compositions and methods for the control of smoking
A composition for the control of smoking which comprises: (a) a flavonoid in the form of an extract from Eupatorium cannibium or Eupatorium Fortunei , preferably euparin; (b) a cytochrome P450...
|
|
|
6743770 |
Nutritional supplement for the management of stress
A nutritional supplement to be incorporated into the diet of an individual under stress (e.g., chronic stress) is described, comprising a low-glycemic-index carbohydrate, alpha lactalbumin-enriched...
|
|
|
6737405 |
Stabilized protein preparation and process for its preparation
A stabilized protein preparation is described which contains no antithrombin III and is protected against loss of activity during pasteurization by the addition of stabilizers which comprise one or...
|
|
|
6737063 |
FimH adhesin proteins and methods of use
The present invention provides bacterial immunogenic agents for administration to humans and non-human animals to stimulate an immune response. Also provided are methods for vaccination of...
|
|
|
6730660 |
Peritoneal dialysis solutions with polypeptides
The present invention provides an improved dialysis solution. The improved dialysis solution provides for the use of specific polypeptides as an osmotic agent with an additional osmotic agent such...
|
|
|
6730661 |
Nutritional composition which contain non-digestible polysaccharides and use thereof to reduce transport through tight junctions
The present invention relates to the use of one or more non-digestible polysaccharides selected from the group consisting of dextrans having a molecular weight of 8 kD to 40,000 kD, hydrolysed...
|
|
|
6720312 |
Method for controlling the membrane structure of a starch granule
The invention relates to a method for treating patients with type 2 diabetes using a food composition able to control the release of glucose into the patient's blood. This is achieved by the...
|
|
|
6716819 |
Use of xylitol to reduce ionic strength and activate endogenous antimicrobials for prevention and treatment of infections
A method for killing infectious microbial cells by exposing the microbial cells to endogenous antimicrobial compounds. Activation of the antimicrobials is achieved by addition of low permeability,...
|
|
|
6713074 |
Cosmetic composition and method
The cosmetic topical formulation of this invention is directed toward diminishing skin wrinkling, fine line, improving skin tone, and combinations thereof. Preferably, the topical formulation...
|
|
|
6713082 |
Composition comprising carbohydrate and peptide material and its use as an energy supplement after or during physical exercise or as a metabolic nutrient for oral consumption
The invention relates to a composition comprising carbohydrate and peptide material as well as an amount of at least one additional free amino acid selected from the group consisting of leucine and...
|
|
|
6713461 |
Pharmaceutical complex
This invention relates to a complex of eletriptan and a sulphobutylether-beta-cyclodextrin, or a pharmaceutically acceptable salt thereof, and to processes for the preparation of, pharmaceutical...
|
|
|
6710032 |
In situ formation of CLA
This is invention relates to increasing levels of 18:1 trans fatty acids in production animals, the products of which may then be fed to mammals which in turn leads to the production of CLA form...
|
|
|
6703370 |
Use of ribose to treat fibromyalgia
The present invention relates to methods and compositions comprising ribose for the treatment of fibromyalgia syndrome. The methods and compositions of the invention are especially suitable for...
|
|
|
6703371 |
Preparations for reducing oxygen consumption during physical efforts
The invention relates to pharmaceutically active substances from the group comprising midazolam and compounds with a methyl-substituted nitrogen atom that is the ring atom of a nitrogenous...
|
|
|
6703369 |
Lipase inhibiting compositions
A pharmaceutical composition contains at least one inhibitor of lipases and at least one fatty acid ester of polyol. In this composition, the fatty acid ester has a melting point above the body...
|